Start here · since 1996

Psychedelics Guide

More than 500 articles organized by substance and topic: psilocybin, LSD, ayahuasca, DMT, MDMA, mescaline and harm reduction. Rigorous information, without fear and without propaganda.

Featured articles

Explore the largest archive on psychoactive substances, published since 1996

US Psychedelic Helpline: Insights from 25,419 Interactions

A Science Advances paper details 25,419 contacts with the Fireside Project (2021-2026), primarily regarding psilocybin and trip support. Among interactions with recorded history, 2.4% mentioned schizophrenia. The data reflects only those who reached out.

Persistent difficulties after psychedelics or meditation: Emory publishes a protocol for a 1,600-person study

A team led by Emory University has posted on medRxiv the protocol for an observational study that will follow, for one year, people who attribute persistent difficulties to psychedelics or meditation. It is a research plan with no data. The sample is deliberately recruited among affected people, so it is not designed to estimate how often these problems occur.

Mind & Spirit

Inspiring reads for open minds

From our readers

Articles chosen by our community of readers

Send us your story and get featured on our homepage

The Medicinal Side of Five Psychoactive Plants

Mandrake, kratom, opium, yohimbe, and harmel: we review the traditional medicinal uses of five psychoactive plants with critical caution.

Sulbutiamine: What the Evidence Says About This Mild Stimulant

We continue our article on sulbutiamine, a legal stimulant. Read the first installment.

 

Consensual Forced Intoxication: Ethics, Risks, and BDSM Dynamics

A deep dive into forced intoxication within BDSM. We explore ethical foundations, SSC consensus, and essential safety measures for this practice.

Coca Leaf and Ephedra: A European Legal Paradox

January 2008 marked the month when all Dutch shops pulled both dried stems of any ephedra species and any product containing ephedrine—a natural stimulant drug with effects identical to amphetamine, which chemists call deoxyephedrine—from their shelves.

LSD at the End of Life: What the Peter Gasser Trial Revealed

The first clinical trial with LSD in over 40 years explored whether psychedelic therapy could alleviate distress in terminal illness. We review the findings.

News

The latest from the psychedelic world

Latest articles

Browse our most recent articles